Generic Oxima Plus contains Indacaterol 110mcg and glycopyrronium 50mcg, a combination bronchodilator for COPD management.

Description Oxima Plus is an inhalation capsule designed for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It improves airflow and reduces symptoms like breathlessness by relaxing airway muscles.

Benefits Oxima Plus provides effective and sustained bronchodilation for COPD patients, reducing airway resistance and improving lung function. It helps decrease exacerbations and enhances overall respiratory health, allowing better daily activity performance.

Ingredients Each capsule contains Indacaterol 110mcg (as Indacaterol Maleate INN) and Glycopyrronium 50mcg (as Glycopyrronium Bromide BP), both in micronized form for effective inhalation.

Uses and Doses For adults (18 years or older), one inhalation capsule is administered once daily at the same time each day. It is not for use in acute bronchospasm or asthma. Elderly patients can use it at the recommended dose. In patients with severe renal impairment, usage should be based on a risk-benefit assessment.

Side Effects Common side effects include cough, oropharyngeal pain, headache, dry mouth, and gastrointestinal discomfort. Serious but rare effects include cardiovascular issues like tachycardia and arrhythmias, hypersensitivity reactions, vision disturbances, and urinary retention.

How to Use Oxima Plus is for oral inhalation only and should be used once daily with the inhalation device provided. Do not swallow the capsule. Follow the doctor's instructions for proper inhalation technique.

Pregnancy & Lactation Classified under pregnancy category C, its safety in pregnant women has not been established. It should only be used if the benefits outweigh the risks. It is unknown whether it is excreted in breast milk; therefore, caution is advised for lactating mothers.

Precautions and Warnings Oxima Plus should not be initiated during acute COPD deterioration. It should not be used alongside other long-acting beta-agonists (LABA) to avoid overdose risk. Caution is needed in patients with cardiovascular disorders, diabetes, hyperthyroidism, glaucoma, or prostatic hyperplasia. If a paradoxical bronchospasm occurs, discontinue immediately.

Safety Information: This medication is intended for maintenance therapy only. Patients should be monitored for potential side effects, especially those with pre-existing health conditions. Keep out of reach of children.

Indications Oxima Plus is prescribed for long-term maintenance therapy in COPD patients. It is not recommended for asthma treatment or emergency use in acute bronchospasm.

Pharmacology Indacaterol is a long-acting beta2-agonist (LABA) that stimulates intracellular adenyl cyclase, leading to bronchodilation. Glycopyrronium is an anticholinergic that inhibits the M3 receptor, relaxing smooth muscles and improving airflow.

Therapeutic Class Combined bronchodilators.

Storage Conditions Store in a cool and dry place, away from direct sunlight. Keep the capsules in the original packaging to protect them from moisture and ensure proper inhalation device usage.

3 FAQ

1. Can Oxima Plus be used for asthma? No, it is not indicated for asthma treatment and should not be used in asthma patients.
2. How long does it take to work? Effects start within a few hours, but full benefits require consistent daily use.
3. Can the capsule be swallowed? No, the capsule should only be used with the inhalation device provided.

Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult a doctor before using Oxima Plus.

Keywords: COPD treatment, bronchodilator, inhalation capsule, Indacaterol Glycopyrronium, ACI Limited, chronic bronchitis, emphysema relief, lung health, respiratory therapy, long-acting bronchodilator, lung function improvement, airway relaxation, inhaler medication, COPD maintenance, breathing support, lung disease management, prescription medicine, respiratory care, airflow obstruction relief, pulmonary health.